Gary Rothbard

Galantamine, which was found to reduce cocaine use in patients treated with methadone for opioid use disorder, may also be effective in reducing the use of nonprescribed opioids in this population.

Group cognitive behavioral therapy was found to benefit patients with chronic pain with low levels of literacy, education, and cognitive memory more than pain psychoeducation.

Intranasal asalhydromorphone was found to reduce opioid abuse-related effects and hydromorphone exposure when compared with intranasal hydromorphone.

Nearly two-thirds of Canadian patients with chronic pain who had contemplated suicide at some point reported being free from suicidal ideation over the past year.

Treatment with buprenorphine-naloxone hydrochloride or extended-release naltrexone hydrochloride may not be associated with pain induction or aggravation of mild to moderate chronic pain.

Cognitive behavioral therapy was found to be more effective in reducing the use of nonmedical opioids compared with standard methadone drug counseling in patients with chronic pain and opioid use disorder enrolled in methadone maintenance treatment programs.

Baseline depressive symptoms were associated with pain and disability in adolescents with juvenile idiopathic arthritis.

The presence of sleep disorders in children with chronic pain may result in greater pain levels and pain interference, a relationship that may in part be mediated by anxiety and depressive symptoms.

Patients with conversion disorder had higher frequencies of significant stressors than did control patients.

Mindfulness, an awareness of one’s present experience without labeling it as good or bad, is a fundamental skill taught in dialectical behavior therapy group skills training.

Clinician awareness of this issue is essential in order to continue providing effective treatment while attempting to reduce abuse of these prescription drugs.

Researchers calculated age-standardized mortality rates on a county level in the United States between 1980 and 2014, specifically examining rates for self-harm, interpersonal violence, alcohol use, and drug use.

Researchers believe that the large increases in clinical ADHD diagnoses were unlikely to be representative of a real bump in prevalence.

The BFNE-S was determined to be the best self-reported tool for measuring patient social fears.

Despite the recognition that early daily tobacco use likely increases the risk for later psychosis, investigation of the effect of covariates such as substance use, existing psychotic features, or parental/family factors was lacking in the literature.

Individuals with depressive residual symptoms between episodes may have more of a negative course of illness.

There has been much variability in the capacity for pharmacological treatments to help curb alcoholism, and the research community has remained interested in determining specific factors that may predict the efficacy of treatments such as naltrexone.

The researchers noted that automated tests should not be used alone, but should instead be used as part of a comprehensive evaluation that must include clinical judgment and involve traditional assessor-guided cognitive batteries.

These results indicated a persistence of depressive and antisocial symptoms and related behavioral patterns far beyond what has been demonstrated in prior research.

There has been a question of whether antipsychotic medications are truly acting upon “primary” negative symptoms, or whether they are instead improving “secondary” negative symptoms via improvement in positive or depressive symptoms.

These proposals represent 5 key discrepancies between current Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, coding and language and what the Steering Committee believes the coding and language should be amended to.

Metacognition-oriented social skills training may be promising for people with schizophrenia spectrum disorders.

Researchers aimed to clarify whether administration route influenced clinical outcomes, differentiating between oral and long-acting injection forms.

The issue of whether and how prenatal SSRI exposure affects offspring has remained murky.

Weighing the benefits and risks of treatment options for ADHD in women of reproductive age is a clear priority.

Transcranial direct current stimulation may be an effective add-on treatment for bipolar depression.